Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs. It is anticipated that this trend will continue. How will these specialty medications affect the dynamic health care landscape and managed care pharmacy?
This pipeline session will focus on new and emerging specialty medications and explore their likely role in therapy. This session will also discuss the potential impact of these agents on the managed care market.
Learning Objectives: :
At the completion of this activity, participants should be able to: